Experienced Attorneys Fighting for Individuals with Side Effects from Propecia
In 1997, Merck gained approval from the U.S. Food and Drug Administration (FDA) to market Propecia® (finasteride) for the treatment of male pattern baldness. Propecia works inside the cells to convert androgen testosterone into 5α-dihydrotestosterone (DHT), essentially blocking androgen production in the body. Merck claims that men who use Propecia® are likely to see an increase in the number of scalp hairs in the first year of treatment as well as a noted slowing of hair loss.
The label listed the following potential side effects from using Propecia®: erectile dysfunction, decreased libido, breast tenderness and enlargement, and depression. The label also stated that these side effects would go away once you stopped using Propecia®. More serious side effects include breast cancer and an increased risk for developing prostate cancer.
In 2008, Merck began changing Propecia® labels in many European countries after receiving numerous patient complaints of long-term sexual side effects even after treatment was stopped including erectile dysfunction and decreased libido. As of June 2011, Merck has not changed its U.S. labels for Propecia® to address the potential long-term nature of reported sexual side effects.
Lawsuits against Merck have been filed in the U.S. relating to the long-term negative sexual side effects, including erectile dysfunction, breast cancer, and prostate cancer as a result of ingesting Propecia®. If you or a loved one is experiencing any side effects after using Propecia® please contact Cohen & Malad, LLP to speak with one of our experienced product liability/personal injury attorneys to discuss your legal options and help you seek the compensation you deserve.
